Swiss pharma major Novartis is sharpening its strategy in India as a pure-play innovator across core therapy segments, including cardiovascular, oncology, and immunology. The company is moving further up the value chain in India, with early scientific discovery and Phase I studies beginning to take shape.
Business
Novartis seeks to deepen India innovation play
- by The News Vista
- May 10, 2026
- 0 Comments
- Less than a minute
- 2 Views
- 1 week ago

